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Introduction
There are increasing options available for the effective
management of HIV. Treatment regimens have become
simpler and more manageable since the introduction of
HAART fifteen years ago. In this context it is important
to understand how commonly PLHIV switch treatment
s and how the decision to change treatment is nego-
tiated between clinician and patient.
Materials and methods
We conducted an online survey of 254 people living
with HIV (PLHIV) in Australia. PLHIV had a median
age of 47.5 years. Overall, 87.4% of respondents were
currently taking ARV; 5.5% had taken ARV in the past
but not currently, and 7.1% had never taken ARV.
Results
Two-thirds of respondents had changed ARV at some
point: 14% in the last 12 months. Respondents last
changed treatment a median of 3 years ago. Most
respondents (90%) had not used more than six combina-
tions in their lifetime.
Of those who had changed treatment, the most signifi-
cant driver of the decision was the advice of the physi-
cian (76%) the second most important was the side
effects of the previous regimen (49%). Fatigue/loss of
energy was the most prevalent side effect experienced
by 74% of all respondents. It was also rated as the most
bothersome on the ACTG-HIS scale.
Aspects associated with adherence were the lowest
rated drivers of treatment change. Only 7% of
respondents identified problems with taking doses at the
correct time, and less than 5% reported missing doses.
Given that the doctor’s advice was the most important
driver of treatment change we elicited the important
characteristics of the clinician- patient relationship using
free text. The doctors’ interpersonal skills and personal-
ity was most frequently identified (by 62% of respon-
dents). This was more than double the next most
frequently mentioned characteristic (competence- 37%).
Open ended contributions from participants also high-
lighted the importance of open communication and a
robust relationship with the clinician.
Conclusions
A focus on adherence and neglect of relational, psycho-
social and somatic factors in assessing motivations for
treatment switching is likely to compromise robust
patient-clinician relationships.
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